We digested plasma and IgM with a mannosidase or a sialidase and determined that the ADCD for the Spike S1 antigen was significantly reduced when IgM from severe COVID-19 was treated with either a mannosidase or a sialidase. Here, CD40LG is linked to COVID-19.